` Comparison: BH vs 300015 - Alpha Spread

BH
vs
A
300015

Over the past 12 months, BH has significantly outperformed Aier Eye Hospital Group Co Ltd, delivering a return of +4% compared to the Aier Eye Hospital Group Co Ltd's 24% drop.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
BH
300015
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

BH Intrinsic Value
HIDDEN
Show
Aier Eye Hospital Group Co Ltd Intrinsic Value
HIDDEN
Show
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Bumrungrad Hospital PCL
SET:BH
203 THB
A
Aier Eye Hospital Group Co Ltd
SZSE:300015
10.59 CNY
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
BH, 300015

BH
300015
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Bumrungrad Hospital PCL
Revenue
A
Aier Eye Hospital Group Co Ltd
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
BH, 300015

BH
300015
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Bumrungrad Hospital PCL
SET:BH
A
Aier Eye Hospital Group Co Ltd
SZSE:300015
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

BH
51.7%
Aier Eye Hospital Group Co Ltd
46.6%

Operating Margin

BH
36.2%
Aier Eye Hospital Group Co Ltd
20.3%

Net Margin

BH
29.9%
Aier Eye Hospital Group Co Ltd
14.5%

FCF Margin

BH
24.5%
Aier Eye Hospital Group Co Ltd
18.1%

ROE

BH
25.7%
Aier Eye Hospital Group Co Ltd
15.3%

ROA

BH
21.7%
Aier Eye Hospital Group Co Ltd
9.4%

ROIC

BH
36.2%
Aier Eye Hospital Group Co Ltd
13.9%

ROCE

BH
29.7%
Aier Eye Hospital Group Co Ltd
16.6%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
BH, 300015

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
BH, 300015

Performance Gap Between BH and 300015
HIDDEN
Show

Performance By Year
BH, 300015

Loading
BH
300015
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare BH to other stocks
HCA
HCA Healthcare Inc
Cheaper
vs BH
4013
Dr Sulaiman Al-Habib Med...
More expensive
vs BH
NTC
Netcare Ltd
N
Cheaper
vs BH
THC
Tenet Healthcare Corp
Cheaper
vs BH
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett